Bristol-Myers Squibb Company (BMY) Stock Analysis

Free AI-powered analysis and research for Bristol-Myers Squibb Company stock

Sector: Healthcare

Analyze Bristol-Myers Squibb Company (BMY) Stock

Bristol-Myers Squibb Company (BMY) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into BMY stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Bristol-Myers Squibb Company stock.

Analyze BMY Now →

📰 Latest Update

UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms

Tue, March 10, 2026 at 5:19 PM UTC 4 min read

UBS has raised its price target for Bristol-Myers Squibb (BMY) ahead of the anticipated data release for Milvexian, a key drug in the company's pipeline. This adjustment reflects growing confidence in the potential of Milvexian to enhance BMY's portfolio and drive future revenue growth. For investors, this development may indicate a positive outlook for the stock, suggesting potential upside as the data release approaches.

Read full article →